HKG-319

N/A

Report date: 2025/06/25 13:47:22
NME

Base Information

Drug NameHKG-319
Drug Alias Name布瑞哌唑口溶膜（国药瑞福莱药业）布瑞哌唑口溶膜（2.2类改良型）HKG-319HKG319
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChina National Pharmaceutical Group Shanxi Rfl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina National Pharmaceutical Group Shanxi Rfl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A